Jump to content
Borobudur

Smile | Over $200m worldwide

Recommended Posts

Quote

Paramount’s Smile is positively grinning ear-to-ear as the horror pic from director Parker Finn saw a wild 19% upswing in holdovers at the international box office in its second frame. The weekend gross was $17.5M in 61 markets for a $40M offshore cume and $89.9M global to date.

The overseas increase is quite literally gobsmacking — even this year’s mega-holder Top Gun: Maverick, also from Paramount, eased (though very slightly) in its sophomore frame. We’re hearing word of mouth is propelling this pic, not a particular holiday/weather scenario. 

 

Quote

The only new opening market this frame was Korea, where Smile debuted at No. 5 with $335K at 355K locations. In Mexico, the second session was good for $2M, a 26% increase on opening, at No. 1 for a local cume is $4.2M.

 

The UK likewise grossed $2M in the sophomore frame; up 25% from the opening and at No. 1. Local cume is $5.4M.

Germany is perhaps the biggest standout, doubling the first weekend. Running total there is $3.4M.

Other markets smiling on Smile include France ($3.2M cume/+8% from last weekend); Australia ($2.3M cume/+43%) and Spain ($2.2M/+51%).

 

Edited by Borobudur
  • Like 2
Link to comment
Share on other sites

On 10/16/2022 at 11:41 PM, Purple Minion said:

 

 

Quote

This scary strong horror entry had another amazing hold, down just 16% from its sophomore session and adding $16.3M in 61 markets. The offshore cume is now $66.4M for $137.6M worldwide. 

In key results, Germany increased again, this time up 24%, for a $6.6M running cume.

 

The UK saw a slight 14% dip for an $8.1M total to date. Mexico dropped just 25% for $6.1M so far, France was also down 25%, and has grossed $4.8M through Sunday. Spain was off by 29% for a $3.5M total to date and Australia was off 18% for $3.4M.

 

There were further increases in Norway (+25%/$1.3M cume), Netherlands (+7%/$1.3M), Switzerland (+19%/$1.2M) and Austria (+40%/$1.1M).

 

Link to comment
Share on other sites

Smile

After Paramount’s horror Smile opened atop the box office with $22.6M, on the higher end of pre-release projections, it then fell only -18% to repeat in first place with $18.5M. That marked the mildest sophomore weekend drop of any major wide-release film of 2022 so far, horror or otherwise.

In its third weekend, it fell only -32% to $12.5M and second place, behind fellow horror release Halloween Ends. Yet the strong word of mouth for Smile, coupled with the poor word of mouth for Ends, reversed their fates and gave Smile the lead once again on its fourth weekend, declining only -33% to $8.4M.

Now in its fifth frame, with Halloween right around the corner, Smile once again defeats Ends. Smile declines -40% to $5.0M and fourth place. That actually is a bit steeper of a drop than predicted, with projections closer to -25% or -30% then -40%.

Through 31 days, Smile has now earned a $92.3M domestic total. Through the equivalent point in release, that’s:

  • +17% ahead of June’s The Black Phone ($78.6M), despite opening -4% behind ($23.6M)
  • +26% ahead of January’s Scream ($73.2M), despite opening -24% behind ($30.0M)
  • +28% ahead of 2021’s The Conjuring: The Devil Made Me Do It ($61.4M), despite opening -6% behind ($24.1M)

Overseas, Smile has now earned $93.6M overseas in 62 markets, for a $185.9M global total. Top overseas market totals include:

  1. U.K. ($11.5M)
  2. Germany ($9.7M)
  3. Mexico ($7.7M)
  4. France ($7.3M)
  5. Australia ($4.6M)
  • Thanks 1
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.



  • Recently Browsing   0 members

    • No registered users viewing this page.
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use and Guidelines. Feel free to read our Privacy Policy as well.